 |
|
Circulating Insulins"Big" and "Little"
Phillip Gorden, MD;
Jesse Roth, MD
Arch Intern Med. 1969;123(3):237-247.
Abstract
Plasma insulin has been characterized by its biologic, immunologic, physical, and chemical similarity to pancreatic insulin. A higher molecular weight heterogenous component (peak "b") of pancreatic insulin that contains the biosynthetic precursor of insulin (proinsulin) has recently been described. Plasma insulin as measured by radioimmunoassay is composed of at least two components. Filtration of plasma on G-50 Sephadex yields a major component ("little" insulin) which is indistinguishable from the major component of pancreatic insulin and a second component "big" insulin which is less retarded by the gel similar to peak "b." Both components react strongly with insulin antisera and are secreted by the pancreas in response to stimuli of insulin secretion. The characteristics of these recently described components of pancreatic and of plasma insulin are described and discussed.
Author Affiliations
Bethesda, Md
From the Diabetes Section, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Md.
Footnotes
Received for publication Oct 18, 1968; accepted Nov 25.
Reprint requests to Diabetes Section, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Md 20014 (Dr. Gorden).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Glucose Intolerance and Insulin Resistance in Patients With Liver Disease: II. A Study of Etiologic Factors and Evaluation of Insulin Actions
Collins et al.
Arch Intern Med 1970;126:608-614.
ABSTRACT
Proinsulin: Metabolic Effects in the Human Forearm
Fineberg and Merimee
Science 1970;167:998-999.
ABSTRACT
|
